{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T17:28:44Z","timestamp":1747848524174},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.diabres.2021.109093","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T03:03:27Z","timestamp":1634180607000},"page":"109093","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Real-world outcomes of two different sensor-augmented insulin pumps with predictive low glucose suspend function in type 1 diabetes patients"],"prefix":"10.1016","volume":"181","author":[{"given":"J.","family":"Moreno-Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Beato-Vibora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Olvera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Garcia-Seco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gallego-Gamero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Mu\u00f1oz-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.109093_b0005","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977\u201386.","DOI":"10.1056\/NEJM199309303291401"},{"issue":"4","key":"10.1016\/j.diabres.2021.109093_b0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"DCCT\/EDIC Research Group. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2013revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2021.109093_b0015","doi-asserted-by":"crossref","unstructured":"Writing Group for the DCCT\/EDIC Research Group, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015 Jan 6;313(1):45\u201353.","DOI":"10.1001\/jama.2014.16107"},{"key":"10.1016\/j.diabres.2021.109093_b0020","doi-asserted-by":"crossref","unstructured":"Gubitosi-Klug RA, Braffett BH, White NH, Sherwin RS, Service FJ, Lachin JM, et al. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT\/EDIC Study. Diabetes Care. 2017 Aug;40(8):1010\u20136.","DOI":"10.2337\/dc16-2723"},{"key":"10.1016\/j.diabres.2021.109093_b0025","doi-asserted-by":"crossref","unstructured":"Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009 Dec;32(12):2245\u201350.","DOI":"10.2337\/dc09-0750"},{"issue":"4","key":"10.1016\/j.diabres.2021.109093_b0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1002853","article-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","volume":"363","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.diabres.2021.109093_b0035","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1464-5491.2011.03256.x","article-title":"Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial","volume":"28","author":"Hermanides","year":"2011","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"12","key":"10.1016\/j.diabres.2021.109093_b0040","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","article-title":"The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial","volume":"55","author":"Battelino","year":"2012","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2021.109093_b0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1303576","article-title":"Threshold-based insulin-pump interruption for reduction of hypoglycemia","volume":"369","author":"Bergenstal","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2021.109093_b0050","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","article-title":"Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial","volume":"310","author":"Ly","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.diabres.2021.109093_b0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/dia.2011.0292","article-title":"Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study","volume":"14","author":"Garg","year":"2012","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.diabres.2021.109093_b0060","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-8587(19)30150-0","article-title":"Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial","volume":"7","author":"Bosi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2021.109093_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/dc17-1604","article-title":"Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes","volume":"41","author":"Abraham","year":"2018","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2021.109093_b0070","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1089\/dia.2018.0199","article-title":"Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes","volume":"20","author":"Beato-V\u00edbora","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.diabres.2021.109093_b0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13340-019-00408-7","article-title":"The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study","volume":"11","author":"Katayama","year":"2020","journal-title":"Diabetol Int"},{"issue":"9","key":"10.1016\/j.diabres.2021.109093_b0080","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/dme.14043","article-title":"Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK","volume":"36","author":"Choudhary","year":"2019","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"8","key":"10.1016\/j.diabres.2021.109093_b0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.endinu.2018.03.009","article-title":"Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend","volume":"65","author":"G\u00f3mez","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"10","key":"10.1016\/j.diabres.2021.109093_b0090","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2021.109093_b0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/dia.2019.0190","article-title":"Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort","volume":"21","author":"M\u00fcller","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.diabres.2021.109093_b0100","first-page":"714","article-title":"Real world improvements in hypoglycemia in an insulin-dependent cohort with diabetes mellitus pre\/post tandem basal-iq technology remote software update","volume":"26","author":"Pinsker","year":"2020","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2021.109093_b0105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.diabres.2021.109093_b0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0212-6567(02)70623-9","article-title":"Quality-of-life questionnaire designed for diabetes mellitus (EsDQOL)","volume":"29","author":"Millan","year":"2002","journal-title":"Aten Primaria"},{"issue":"5","key":"10.1016\/j.diabres.2021.109093_b0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.endinu.2017.12.003","article-title":"Spanish translation, adaptation and validation of the Hypoglycemia Fear Survey in adults with type 1 diabetes in the Community of Madrid","volume":"65","author":"Tasende","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"2","key":"10.1016\/j.diabres.2021.109093_b0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/193229681100500236","article-title":"GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data","volume":"5","author":"Czerwoniuk","year":"2011","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721004526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721004526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T16:27:20Z","timestamp":1714580840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721004526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":24,"alternative-id":["S0168822721004526"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.109093","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world outcomes of two different sensor-augmented insulin pumps with predictive low glucose suspend function in type 1 diabetes patients","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.109093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109093"}}